daopei lu

Daopei Lu, Academician

  • -Chief scientist, world-famous hematologist and China key discipline leader
  • -Founder of Institute of Hematology, Peking University
  • -Distinguished Professor at Peking University, Fudan University and Wuhan University
-Successfully completed the first syngeneic bone marrow transplantation in Asia (1964).
-Successfully completed the first allogeneic bone marrow transplantation in China (1981).
-Successfully completed the first major ABO-incompatible bone marrow transplantation in China (late 1980s).
-For the first time, it proved that arsenic sulfide has a significant effect on some leukemia (1995).
-Unprecedentedly guided to establish the cord blood bank in China (1997).
-Successfully completed the first allogeneic umbilical cord blood transplantation and systematically developed this transplantation in China (1997).
-Firstly applied some immunotherapies to control acute leukemia and obtained a remarkable therapeutic efficacy.
-Firstly identified three hereditary blood diseases in China.
-Firstly reported the remarkable efficacy of lithospermum and its extract on vascular purpura and phlebitis.
-As the editor-in-chief, associate editor-in-chief or editorial board member of 8 Chinese medical journals and the editorial board member of two international journals like Bone Marrow Transplantation and Journal of Hematology & Oncology. Published over 400 papers/books including 4 complied monographs like Leukemia Therapeutics and attended the composing of 19 publications.
-Second prize of National Scientific and Technological Progress Award (1985).
-The 7th Tan Kah Kee Prize in Medical Sciences (1997).
-The 3rd Ho Leung Ho Lee Science and Technology Progress Award (1997).
-First Prize of Beijing Science and Technology Award (2006).
-Distinguished Service Contribution Award from CIBMTR (2016).
-Lifetime Achievement Award from China Anti-Cancer Association (2016).